S&W Seed Company (SANW) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
A special meeting of stockholders will be held virtually on September 26, 2024, to vote on a proposed reverse stock split of common stock at a ratio between 1-for-5 and 1-for-20, with the exact ratio and timing to be determined by the Board, but no later than January 31, 2025.
The reverse stock split aims to help maintain compliance with Nasdaq's $1.00 minimum bid price requirement and avoid potential delisting, which could negatively impact liquidity and investor interest.
The Board unanimously recommends voting in favor of the reverse stock split proposal.
If approved, the reverse stock split will not affect the percentage ownership of stockholders, except for adjustments due to fractional shares, which will be rounded up to the next whole share.
The company’s authorized shares will remain at 75,000,000, resulting in an effective increase in available shares for future corporate purposes.
Voting matters and shareholder proposals
The sole item for stockholder vote is the approval of a reverse stock split of common stock at a ratio between 1-for-5 and 1-for-20, with the Board having discretion over the exact ratio and timing.
Stockholders of record as of September 3, 2024, are eligible to vote, with each share entitled to one vote.
Approval requires a majority of voting power present virtually or by proxy; abstentions and broker non-votes will count as votes against.
The Board recommends a vote “FOR” the proposal.
Board of directors and corporate governance
The Board retains discretion to determine the reverse stock split ratio and timing within the approved range.
Stockholders may submit proposals or director nominations for the next annual meeting by following SEC and bylaw requirements, with specific deadlines provided.
Latest events from S&W Seed Company
- Double Team sorghum growth drove margin gains, but revenue fell and Australia entered VA.SANW
Q4 202417 Jan 2026 - Q1 revenue fell 22.8% to $8.3M; focus shifts to high-margin U.S. sorghum traits and break-even target.SANW
Q1 202513 Jan 2026 - Revenue and margins fell sharply amid restructuring, with a strategic review underway.SANW
Q2 202524 Dec 2025 - Vote on a reverse stock split to maintain Nasdaq compliance, with Board discretion on ratio and timing.SANW
Proxy Filing1 Dec 2025 - Board recommends approval of all annual meeting proposals, including expanded equity incentives.SANW
Proxy Filing1 Dec 2025 - Key votes include board elections, auditor ratification, and executive pay at the 2024 annual meeting.SANW
Proxy Filing1 Dec 2025 - Gross margin hit 37.7% and Adjusted EBITDA turned positive, but tariffs and liquidity risks remain.SANW
Q3 202527 Nov 2025